“…Early reports of PET imaging agents for the progesterone receptor (PgR), published in the 1970s and 1980s, described the synthesis of 21-[ 18 F]fluoroprogesterone, a direct analog of the endogenous progestational hormone, progesterone, as well as some analogs of this compound and ones substituted at different sites; however, no PgR binding was reported, and biodistribution and metabolism studies were limited and generally disappointing [ 60 , 61 , 62 ]. High-affinity radioiodinated ligands for PgR, reported at the same time, appeared more promising, especially (Z)-17β-hydroxy-17α-(2-iodovinyl)-4-estren-3-one and the bromo analog [ 63 , 64 , 65 , 66 , 67 ], and these showed some evidence of PgR-specific uptake in the uterus of estrogen-primed immature rats [ 24 , 68 ].…”